Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide versus risedronate for severe postmenopausal osteoporosis with vertebral fractures
2012-000123-41Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of teriparatide and risedronate in postmenopausal osteoporosis (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Incidence of new vertebral fractures. Started Jul 2012; status: completed.
02
Drugs
teriparatiderisedronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on 2012-000123-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000123-41.